Clinical Trial Update: The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in Patients With Kidney Transplantation: a Prospective Intervention Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 prospective pilot study evaluating rifamycin-containing regimens for latent tuberculosis infection in kidney transplant patients, focusing on safety, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Latent Tuberculosis Infection

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Pulmonology | Phase 4 | Status: RECRUITING